Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03260322
Title A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | ESP | CAN

Facility Status City State Zip Country Details
Honor Health Research Institute Scottsdale Arizona 85258 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
University of California, Davis Sacramento California 95817 United States Details
University of California, San Francisco San Francisco California 94115 United States Details
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
University of Kansas Cancer Center Fairway Kansas 66205 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
Columbia University Medical Center New York New York 10032 United States Details
University Hospital of Cleveland Cleveland Ohio 44106 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Mary Crowley Research Center Dallas Texas 75251 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226-3522 United States Details
Site CA15004 Edmonton Alberta T6G 1Z2 Canada Details
Site CA15003 Toronto Ontario M4N 3M5 Canada Details
Site CA15001 Toronto Ontario M5G 2M9 Canada Details
Site CA15002 Montreal Quebec H3T 1E2 Canada Details
Site IT39004 Ancona Italy Details
Site IT39002 Milano Italy Details
Site IT39003 Milano Italy Details
Site IT39008 Milano Italy Details
Site IT39009 Milano Italy Details
Site IT39010 Modena Italy Details
Site IT39005 Monza Italy Details
Site IT39011 Negrar Italy Details
Site JP81001 Chuo-ku Japan Details
Site KR82004 Goyang-si Gyeonggi-do 410-769 Korea, Republic of Details
Site KR82005 Seongnam-Si Gyeonggi-do 013620 Korea, Republic of Details
Site KR82001 Seoul 03080 Korea, Republic of Details
SIte KR82002 Seoul 120-752 Korea, Republic of Details
Site KR82006 Seoul Korea, Republic of Details
Site PT35101 Lisboa Portugal Details
Site PT35106 Porto Portugal Details
Site ES34002 Barcelona Spain Details
Site ES34003 Barcelona Spain Details
Site ES34009 Barcelona Spain Details
Site ES34010 Barcelona Spain Details
Site ES34001 Madrid Spain Details
Site ES34006 Madrid Spain Details
Site ES34013 Madrid Spain Details
Site ES34014 Valencia Spain Details
Site TW88602 Taichung 00404 Taiwan Details
Site TW88601 Tainan Taiwan Details
Site TW88603 Taipei City Taiwan Details
Site GB44003 London United Kingdom Details
Site GB44006 London United Kingdom Details
Site GB44004 Newcastle upon Tyne United Kingdom Details
Site GB44005 Sutton Surry United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field